Cetera Trust Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.1K Hold
1,000
0.02% 243
2025
Q4
$24.9K Hold
1,000
0.01% 246
2025
Q3
$25.5K Hold
1,000
0.01% 243
2025
Q2
$24.2K Sell
1,000
-182
-15% -$4.24K 0.01% 244
2025
Q1
$30K Sell
1,182
-250
-17% -$6.54K 0.02% 240
2024
Q4
$38K Sell
1,432
-223
-13% -$6.05K 0.02% 233
2024
Q3
$47.9K Hold
1,655
0.03% 235
2024
Q2
$46.3K Sell
1,655
-200
-11% -$5.51K 0.03% 232
2024
Q1
$51.5K Hold
1,855
0.03% 228
2023
Q4
$53.4K Buy
+1,855
New +$56.1K 0.03% 223

Other funds holding PFE

Cetera Trust Company's PFE Position: Q1 2026 in Review

Cetera Trust Company held its Pfizer (PFE) position steady in Q1 2026 at 1,000 shares worth $28.1K. The position accounts for 0.02% of the portfolio, ranked #243.

Cetera Trust Company first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $53.4K in Q4 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cetera Trust Company held 1,000 shares of Pfizer worth $28.1K as of Q1 2026.
  • Cetera Trust Company left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.02% of Cetera Trust Company's portfolio in Q1 2026, its #243 holding.
  • Cetera Trust Company first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Cetera Trust Company's Pfizer position peaked at $53.4K in Q4 2023.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.